IllnessRendu-Osler-Weber disease, differential diagnosis
Summary
Comprehensive differential diagnostic panel for Rendu-Osler-Weber disease comprising 3 guideline-curated genes and altogether 9 curated genes according to the clinical signs
24,8 kb (Extended panel: incl. additional genes)
- EDTA-anticoagulated blood (3-5 ml)
NGS +
[Sanger]
Gene panel
Informations about the disease
Rendu-Osler-Weber disease (hereditary hemorrhagic telangiectasia) is a rare disorder that affects blood vessels throughout the body, causes vascular dysplasia and leads to a tendency to bleed. The prognosis varies depending on the severity of the symptoms, but is generally good. Muco-cutaneous telangiectasias and arteriovenous malformations occur as well as lesions in the nasopharynx, central nervous system, lungs, liver, spleen and in the urinary and gastrointestinal tracts, conjunctiva, trunk etc. 50% of patients have nose bleeds by their tenth birthday, >80% by the age of 21. Practically all of them develop recurrent epistaxis and later (muco-)cutaneous telangiectasias. Cerebral arteriovenous malformations are almost always congenital. Hereditary hemorrhagic telangiectasia is inherited autosomal dominantly with considerable intrafamilial variability and age-related penetrance with more manifestations in older age. The diagnostic yield is over 75%. An inconspicuous genetic finding does not exclude a suspected clinical diagnosis.
Reference: https://www.ncbi.nlm.nih.gov/books/NBK1351/
- Alias: Hereditary haemorrhagic telangiectasia
- Alias: Hereditäre hämorragische Teleangiektasie
- Alias: Morbus Osler
- Alias: Osler-Weber-Rendu Disease
- Alias: Rendu-Osler disease
- Allelic: Basal cell carcinoma, somatic (RASA1)
- Allelic: Breast cancer, susceptibility to (ATM)
- Allelic: Lymphatic malformation 7 (EPHB4)
- Allelic: Myhre syndrome (SMAD4)
- Allelic: Pancreatic cancer, somatic (SMAD4)
- Allelic: Polyposis, juvenile intestinal (SMAD4)
- Allelic: Pulmonary arterial hypertension (ACVRL1)
- Allelic: Pulmonary hypertension, familial primary, 1, with/-out HHT (BMPR2)
- Allelic: Pulmonary hypertension, primary, fenfluramine-/dexfenfluramine-associated (BMPR2)
- Ataxia-telangiectasia (ATM)
- Capillary malformation-arteriovenous malformation 1 (RASA1)
- Capillary malformation-arteriovenous malformation 2 (EPHB4)
- Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (SMAD4)
- Pulmonary venoocclusive disease 1 (BMPR2)
- Telangiectasia, hereditary hemorrhagic, type 1 (ENG)
- Telangiectasia, hereditary hemorrhagic, type 2 (ACVRL1)
- Telangiectasia, hereditary hemorrhagic, type 5 (GDF2)
- von Willebrand disease, types 1, 2A, 2B, 2M, 2N, 3
- AD
- AR
- Multiple OMIM-Ps
Bioinformatics and clinical interpretation
No text defined